Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

Forecast of new brand and LOE impact in developed pharma markets 2019-2026

Published by
Matej Mikulic,
Mar 27, 2023
This statistic shows the forecast of new brand and brand loss of exclusivity (LOE) impact in developed pharma markets from 2019 to 2026, in billion U.S. dollars. According to the forecast, in 2022, the loss of exclusivity is expected to have a negative impact of some 32 billion U.S. dollars while the new brand spending would be a gain of 31 billion U.S. dollars.

Forecast of new brand and brand loss of exclusivity (LOE) impact in developed pharmaceutical markets from 2019 to 2026 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2021

Region

Worldwide

Survey time period

as of November 2021

Supplementary notes

Developed markets include: U.S., Japan, Germany, France, Italy, U.K., Spain, Canada, S.Korea, Australia; LOE = loss of exclusivity.
All values are rounded estimates/forecasts and in constant U.S. dollars.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Generics and biosimilars "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars

Global overview

4

Top companies

4

U.S. market

6

Patent expiration

6

Savings

7

Biosimilars

7

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in the PhilippinesInsurance industry in the PhilippinesDemographics of the PhilippinesCoronavirus (COVID-19) pandemic in the PhilippinesHealthcare industry in the Philippines
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu